Robert
A. Wolff, M.D. - Medical Oncology
Dr. Wolff is board
certified in three different fields: Medicine, Hematology and Oncology.
For the past several years he has been interested in the clinical
management of gastrointestinal tumors with particular interest in
pancreatic cancer treatment. Dr. Wolff has worked both at Duke Universtiy
and MD Anderson to design clinical protocols combining chemotherapy
and radiation as preoperative treatment for pancreatic and rectal
cancers, and as part of the treatment for more advanced tumors.
Education:
- Medical
School: Albany Medical College, Albany NY (1986)
- Residency
(Internal Medicine): Duke University Medical Center, Durham, NC,
(1986-1989)
- Fellowship
(Hematology and Oncology): Duke University Medical Center, Durham,
NC 1989-1992.
Selected References :
1. Wolff RA,
Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Goswitz
MS, Abbruzzese JL. Phase I trial of gemcitabine combined with radiation
for the treatment of locally advanced pancreatic adenocarcinoma.
Abstract. Proceedings American Society of Clinical Oncology, Los
Angeles, CA 1998.
2. Pisters
PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz
MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB. Rapid-fractionation
preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative
radiation therapy for resectable pancreatic adenocarcinoma. Journal
of Clinical Oncology 16(12):3843-50, 1998.
3. White R,
Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz
H, Tyler D. Preoperative chemoradiation for patients with locally
advanced adenocarcinoma of the pancreas. Annals of Surgery. (in
press)
|